As FDA states in their guidance document on the Q-Submission program, Early interaction with FDA on planned non-clinical and clinical studies and careful consideration of FDAs feedback may improve the quality of subsequent submissions, shorten total review times, and facilitate the development process for new devices. While this is not meant to be a general pre-review of your submission, it is there to help you get answers to questions directly from FDAwhich will contribute to a smooth submission and, hopefully, approval
Our products ticks these boxes which is why it stands out among Indian options
Activity in the dorsal cochlear nucleus of hamsters previously tested for tinnitus following intense tone exposure
Apply appropriate amount to the face
Its not something new: it was introduced around 1950 and today it can be used up to 1% worldwide
In 2023, the FDA placed 19 widely used peptides on a restricted list that effectively prevented compounding pharmacies from producing them